Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02872207 · ClinicalTrials.gov registry record · NA
Evaluation of the Stinging Potential in Human Eyes
A NA study of Sunscreen Agents, sponsored by Bayer.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT02872207: Completed NA study of Sunscreen Agents, sponsored by Bayer.
NCT02872207 is a NA study of Sunscreen Agents that has completed, run by Bayer. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02872207, a NA study of Sunscreen Agents, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study was to compare the human eye stinging potential of experimental formulas and an industry standard shampoo mixture. The study was conducted under the supervision of a Board Certified Ophthalmologist.
Conditions Studied
Interventions
- DRUG Control
- DRUG BAY 987516 (Y65-122)
- DRUG BAY 987516 (Y65-118)
Study Locations (1)
Florida
- - St. Petersburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2015-02-21 |
| Est. Completion | 2015-02-22 |
| Phase | NA |
What the finished NCT02872207 record still lists
NCT02872207 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Sunscreen Agents appearing as the primary indexed condition, and to 3 interventions - of which Control is the first listed.
NCT02872207 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT02872207 about?
NCT02872207 is a clinical study titled "Evaluation of the Stinging Potential in Human Eyes". The objective of this study was to compare the human eye stinging potential of experimental formulas and an industry standard shampoo mixture. The study was conducted under the supervision of a Board Certified Ophthalmologist.
What is the current status of trial NCT02872207?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2015-02-21. Estimated completion is 2015-02-22.
What conditions does trial NCT02872207 study?
This clinical trial studies the following conditions: Sunscreen Agents.
What interventions are being tested in trial NCT02872207?
The interventions under investigation include: Control (DRUG), BAY 987516 (Y65-122) (DRUG), BAY 987516 (Y65-118) (DRUG).
Who is sponsoring clinical trial NCT02872207?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02872207 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sunscreen Agents
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02872207's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI